Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of MRI Biomarkers Predictive of Disability Progression in Patients With Multiple Sclerosis

NCT05491031 is registered in ClinicalTrials.gov with Poitiers University Hospital as lead sponsor.

NCT NCT05491031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05491031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of MRI Biomarkers Predictive of Disability Progression in Patients With Multiple Sclerosis
Lead sponsor
Poitiers University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
April 25, 2023
Completion date
May 1, 2030
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

magnetic resonance spectroscopy, multiple sclerosis